English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksAjanta Pharma share price falls 2% on Nifty Midcap 150

    Ajanta Pharma share price falls 2% on Nifty Midcap 150

    The stock is currently trading at Rs 2,728.60, reflecting the recent market activity.

    Alpha Desk
    July 28, 2025 / 12:13 IST
    Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Shares of Ajanta Pharma declined by 2% to trade at Rs 2,728.60 in Monday's session. At 12:07 pm, the stock experienced this fall, reflecting a notable shift in investor sentiment. The stock is trading on the Nifty Midcap 150.

      Financial Overview:

      Ajanta Pharma's financial performance shows consistent growth in both quarterly and annual results. Here's a summary of the company's financial performance:

      Consolidated Quarterly Performance:

      HeadingMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      RevenueRs 1,054.08 CroreRs 1,144.92 CroreRs 1,186.64 CroreRs 1,146.13 CroreRs 1,170.41 Crore
      Net ProfitRs 202.72 CroreRs 245.77 CroreRs 216.48 CroreRs 232.88 CroreRs 225.26 Crore
      EPS16.1019.5417.2718.6018.00

      The revenue for Ajanta Pharma has shown a steady increase over the quarters, with revenue for the quarter ending March 2025 at Rs 1,170.41 Crore compared to Rs 1,054.08 Crore in March 2024. Net profit also increased, with Rs 225.26 Crore reported for March 2025 compared to Rs 202.72 Crore in March 2024.

      Consolidated Yearly Performance:

      Heading20212022202320242025
      RevenueRs 2,889.69 CroreRs 3,340.99 CroreRs 3,742.64 CroreRs 4,208.71 CroreRs 4,648.10 Crore
      Net ProfitRs 653.87 CroreRs 712.68 CroreRs 587.98 CroreRs 816.17 CroreRs 920.39 Crore
      EPS75.0982.4545.8964.8273.56
      BVPS344.52380.24268.14282.34302.38
      ROE21.8221.8317.3522.8724.28
      Debt to Equity0.000.000.000.000.00

      The annual revenue has consistently increased, from Rs 2,889.69 Crore in 2021 to Rs 4,648.10 Crore in 2025. Similarly, the net profit has also grown, with Rs 920.39 Crore reported in 2025 compared to Rs 653.87 Crore in 2021.

      Consolidated Yearly Income Statement:

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      SalesRs 4,648 CroreRs 4,208 CroreRs 3,742 CroreRs 3,340 CroreRs 2,889 Crore
      Other IncomeRs 94 CroreRs 84 CroreRs 98 CroreRs 115 CroreRs 25 Crore
      Total IncomeRs 4,742 CroreRs 4,293 CroreRs 3,841 CroreRs 3,456 CroreRs 2,915 Crore
      Total ExpenditureRs 3,532 CroreRs 3,172 CroreRs 3,090 CroreRs 2,536 CroreRs 2,007 Crore
      EBITRs 1,209 CroreRs 1,121 CroreRs 751 CroreRs 919 CroreRs 908 Crore
      InterestRs 20 CroreRs 7 CroreRs 5 CroreRs 10 CroreRs 8 Crore
      TaxRs 268 CroreRs 297 CroreRs 157 CroreRs 196 CroreRs 246 Crore
      Net ProfitRs 920 CroreRs 816 CroreRs 587 CroreRs 712 CroreRs 653 Crore
      Consolidated Quarterly Income Statement:
      Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      SalesRs 1,170 CroreRs 1,146 CroreRs 1,186 CroreRs 1,144 CroreRs 1,054 Crore
      Other IncomeRs 18 CroreRs 30 CroreRs 19 CroreRs 26 CroreRs 35 Crore
      Total IncomeRs 1,188 CroreRs 1,176 CroreRs 1,206 CroreRs 1,171 CroreRs 1,089 Crore
      Total ExpenditureRs 913 CroreRs 861 CroreRs 909 CroreRs 848 CroreRs 810 Crore
      EBITRs 275 CroreRs 315 CroreRs 296 CroreRs 322 CroreRs 279 Crore
      InterestRs 6 CroreRs 7 CroreRs 6 CroreRs 0 CroreRs 1 Crore
      TaxRs 44 CroreRs 74 CroreRs 73 CroreRs 76 CroreRs 75 Crore
      Net ProfitRs 225 CroreRs 232 CroreRs 216 CroreRs 245 CroreRs 202 Crore
      Consolidated Balance Sheet:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Share CapitalRs 25 CroreRs 25 CroreRs 25 CroreRs 17 CroreRs 17 Crore
      Reserves & SurplusRs 3,765 CroreRs 3,536 CroreRs 3,362 CroreRs 3,247 CroreRs 2,978 Crore
      Current LiabilitiesRs 996 CroreRs 895 CroreRs 1,139 CroreRs 647 CroreRs 648 Crore
      Other LiabilitiesRs 228 CroreRs 180 CroreRs 152 CroreRs 143 CroreRs 134 Crore
      Total LiabilitiesRs 5,014 CroreRs 4,638 CroreRs 4,679 CroreRs 4,055 CroreRs 3,778 Crore
      Fixed AssetsRs 1,938 CroreRs 1,735 CroreRs 1,705 CroreRs 1,664 CroreRs 1,649 Crore
      Current AssetsRs 2,843 CroreRs 2,730 CroreRs 2,834 CroreRs 2,264 CroreRs 2,027 Crore
      Other AssetsRs 233 CroreRs 171 CroreRs 139 CroreRs 126 CroreRs 101 Crore
      Total AssetsRs 5,014 CroreRs 4,638 CroreRs 4,679 CroreRs 4,055 CroreRs 3,778 Crore
      Contingent LiabilitiesRs 144 CroreRs 161 CroreRs 91 CroreRs 76 CroreRs 168 Crore
      Cash Flow:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Operating ActivitiesRs 1,157 CroreRs 785 CroreRs 791 CroreRs 562 CroreRs 576 Crore
      Investing ActivitiesRs -376 CroreRs 65 CroreRs -559 CroreRs -74 CroreRs -282 Crore
      Financing ActivitiesRs -733 CroreRs -1,051 CroreRs -107 CroreRs -460 CroreRs -318 Crore
      OthersRs 0 CroreRs 0 CroreRs 0 CroreRs 0 CroreRs 0 Crore
      Net Cash FlowRs 47 CroreRs -200 CroreRs 124 CroreRs 27 CroreRs -24 Crore
      Key Financial Ratios:
      RatioMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Basic EPS (Rs.)73.5664.8245.8982.4575.09
      Diluted EPS (Rs.)73.5364.7745.8982.4575.09
      Book Value / Share (Rs.)302.38282.34268.14380.24344.52
      Dividend/Share (Rs.)28.0051.007.009.509.50
      Face Value22222
      Gross Profit Margin (%)29.1329.8523.5631.2735.45
      Operating Margin (%)26.0226.6320.0627.5231.43
      Net Profit Margin (%)19.8019.3915.7121.3322.62
      Return on Equity (%)24.2822.8717.3521.8321.82
      ROCE (%)30.1029.9521.2126.9829.02
      Return On Assets (%)18.3517.5912.5617.5717.30
      Current Ratio (X)2.853.052.493.503.13
      Quick Ratio (X)1.952.121.772.281.94
      Debt to Equity (x)0.000.000.000.000.00
      Interest Coverage Ratios (X)65.32174.28151.01102.45123.89
      Asset Turnover Ratio (%)0.960.900.820.830.79
      Inventory Turnover Ratio (X)0.981.141.191.101.25
      3 Yr CAGR Sales (%)17.9520.6820.2627.4916.59
      3 Yr CAGR Net Profit (%)13.6411.7212.1235.7118.12
      P/E (x)35.6634.4226.3414.6415.91
      P/B (x)8.667.934.514.765.21
      EV/EBITDA (x)24.1122.4016.9514.6615.02
      P/S (x)7.066.724.084.655.40
      Corporate Actions:

      Ajanta Pharma has announced several corporate actions, including shareholder meetings, postal ballots, and dividend payouts.

      • Shareholder Meeting/Postal Ballot: A shareholder meeting was held, and the scrutinizer's report was enclosed, pursuant to Regulation 44 of SEBI LODR Regulations.
      • Outcome of AGM: The proceedings of the AGM were enclosed, pursuant to Regulation 30 of SEBI LODR Regulations, 2015.
      • Analyst/Investor Meet: An intimation for an investor call was announced.
      Dividends:
      • October 25, 2024: An interim dividend of Rs. 28.00 per share (1400%) was announced, with an effective date of November 6, 2024.
      • January 25, 2024: An interim dividend of Rs. 26.00 per share (1300%) was announced, with an effective date of February 8, 2024.
      Bonus Issues:
      • May 10, 2022: A bonus ratio of 1:2 was announced, with a record date of June 23, 2022, and an ex-bonus date of June 22, 2022.
      • July 29, 2013: A bonus ratio of 1:2 was announced, with a record date of September 18, 2013, and an ex-bonus date of September 17, 2013.
      Stock Splits:
      • January 28, 2015: The face value was split from Rs 5 to Rs 2, with an ex-split date of March 20, 2015, and a record date of March 23, 2015.
      • April 26, 2012: The face value was split from Rs 10 to Rs 5, with an ex-split date of August 9, 2012, and a record date of August 10, 2012.

      Overall, Moneycontrol analysis suggests a very bullish sentiment for Ajanta Pharma as of July 28, 2025.

      The stock is currently trading at Rs 2,728.60, reflecting the recent market activity.

      Alpha Desk
      first published: Jul 28, 2025 12:13 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347